8-K
Current Report
Alaunos Therapeutics, Inc. Filed Acc 0000950170-25-095029
Shareholder rights changed · Shareholder vote results
- Item 3.03 Material modification to rights of security holders
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading tcrt-20250703.htm…